News FocusVirology

Capitalizing on HIV's Talents for Gene Therapy

See allHide authors and affiliations

Science  08 Dec 2000:
Vol. 290, Issue 5498, pp. 1878
DOI: 10.1126/science.290.5498.1878

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution


The emerging understanding of HIV's journey from the cell membrane to the nucleus may help researchers design better vectors for gene therapy for a variety of diseases. Researchers are using HIV itself as a gene-therapy vector, thereby capitalizing on its ability to infect nondividing cells.